"Board Certified Medical Oncologists and Medical Oncology & Hematology Specialists located in Flemington, New Jersey of Hunterdon County"

During the past decade, Hunterdon Hematology Oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hunterdon Hematology Oncology" #1 sponsor was "BeiGene" with 1 trials, followed by "Biological Dynamics" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Egetis Therapeutics" with 1 trials sponsored and "Galera Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hunterdon Hematology Oncology" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Legend Biotech" with 1 trials as a collaborator and "Solasia Pharma K.K." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hunterdon Hematology Oncology" are "Multiple Myeloma" (3 trials), "Breast Neoplasms" (1 trials), "Cachexia; Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Chemotherapy-induced Peripheral Neuropathy" (1 trials). Many other conditions were trialed in "Hunterdon Hematology Oncology" in a lesser frequency.

Most popular intervention types in "Hunterdon Hematology Oncology" are "Drug" (6 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Calmangafodipir (2 µmol/kg)" (1 trials), "Calmangafodipir (5 µmol/kg)" (1 trials), "Dexamethasone" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hunterdon Hematology Oncology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hunterdon Hematology Oncology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hunterdon Hematology Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hunterdon Hematology Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".